| | | |   | | | | By Ed Silverman Mark Wilson/Getty Images “Shkreli was the prime mover in this anticompetitive scheme. It was his brainchild and he drove it each step of the way," the judge wrote. Read More | | By Rachel Cohrs Jessica Rinaldi/The Boston Globe Medicare has unveiled a plan to cover a controversial, expensive new Alzheimer's drug, but has not said how much patients might pay Read More | | By Angus Chen Molly Ferguson for STAT Scientists are working on the next generation of CAR-T therapies — from armored CARs to controllable CARs — to combat cancer. Read More | | Sponsor content by Alkermes A new era for neuroscience and oncology drug development: The biopharma driving R&D innovation Among the most incredible achievements of humankind over the last few decades are the indisputable advancements in medical science — remarkable treatments that contribute to longer, healthier lives worldwide. Yet, despite awe-inspiring innovations, millions of people live with complicated, difficult-to-treat conditions for which there remain limited or no treatment options. Alkermes is working to change this. Read the article here. | | By Ed Silverman Alex Hogan/STAT From new hires to departures, transfers, and promotions, here are the latest comings and goings in the pharmaceutical industry. Read More | |
No comments